Quantum Lens
Making the undruggable druggable
A physics native platform built to see what others can’t: revealing novel chemical space and generating diverse hits for the hardest targets in drug discovery.
Patented quantum and AI technology, built for biotech, pharma and CRO partners who need speed and precison at enterprise scale.
Drug Discovery Service
Covalent Inhibitor Design
Quantum Lens for Covalent Inhibitor Design is a great way to evaluate our service and platform capabilities since the work is proven to be well-defined, with a clear scope and timeline and demonstrates the platform’s precision on a real target.
Using quantum fingerprinting, we characterise warhead reactivity and selectivity in your target's true protein environment, going beyond conventional HOMO/LUMO approximations that routinely fail for reactive systems.
What Quantum Lens Platform delivers:
✓ Targeted covalent inhibitor design
✓ Warhead selection and reactivity prediction
✓ Phosphatase selectivity solutions
✓ Transition-state drug design
✓ Unlocking undruggable enzyme targets
✓ Scaffold hopping and lead optimisation
✓ Quantum fingerprinting for novel chemistry
As a Service:
✓ End to end project management/onboarding
✓ High level tech and physics specialists
Quantum Lens
Enterprise Scale
Quantum Lens can enhance your capabilities inhouse as a biotech and your commercial offer as a CRO.
TEXT HERE
TEXT HERE